Literature DB >> 16914103

Thyroid hormone and heart failure.

Ursula Maria Schmidt-Ott1, Deborah Davis Ascheim.   

Abstract

Thyroid hormone metabolic disarray has been identified as a risk factor for the progression of heart disease and the development of heart failure (HF). Both hyper- and hypothyroidism have been associated with a failing myocardium. Poor cardiac contractility and low cardiac output due to hyperthyroidism is a rare occurrence and is mostly seen in patients with preexisting heart disease. Referred to as a "rate related" phenomenon, hyperthyroid-induced sustained sinus tachycardia or atrial fibrillation may further reduce ventricular contractility. Increasingly, the hypothyroid state, and in particular a low triiodothyronine level, has been associated with a reduced cardiac performance and poor prognosis in HF, even in the presence of normal thyroid-stimulating hormone levels. Low thyroid hormone levels alter cardiac gene expression and increase systemic vascular resistance, both resulting in a reduction of cardiac contractility and cardiac output. This review summarizes current data on thyroid dysfunction and HF as well as the emerging implications of the "low triiodothyronine state."

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914103     DOI: 10.1007/s11897-006-0010-1

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  39 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Subclinical thyroid disease.

Authors:  M I Surks; E Ocampo
Journal:  Am J Med       Date:  1996-02       Impact factor: 4.965

3.  Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure.

Authors:  C Opasich; F Pacini; N Ambrosino; P G Riccardi; O Febo; R Ferrari; F Cobelli; L Tavazzi
Journal:  Eur Heart J       Date:  1996-12       Impact factor: 29.983

4.  The role of selective beta 1-blocker in the preoperative preparation of thyrotoxicosis: a comparative study with propranolol.

Authors:  P Vickers; K M Garg; R Arya; U Godha; P Mathur; S Jain
Journal:  Int Surg       Date:  1990 Jul-Sep

5.  Type 2 iodothyronin deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis.

Authors:  J Pachucki; J Hopkins; R Peeters; H Tu; S D Carvalho; H Kaulbach; E D Abel; F E Wondisford; J S Ingwall; P R Larsen
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

Review 6.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

7.  Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy.

Authors:  P Moruzzi; E Doria; P G Agostoni
Journal:  Am J Med       Date:  1996-11       Impact factor: 4.965

Review 8.  Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state.

Authors:  Deborah D Ascheim; Katarzyna Hryniewicz
Journal:  Thyroid       Date:  2002-06       Impact factor: 6.568

9.  Acute effects of thyroid hormone on vascular smooth muscle.

Authors:  K Ojamaa; J D Klemperer; I Klein
Journal:  Thyroid       Date:  1996-10       Impact factor: 6.568

Review 10.  Hyperthyroidism: a "curable" cause of congestive heart failure--three case reports and a review of the literature.

Authors:  Kamran Riaz; Alan D Forker; William L Isley; Mitchell S Hamburg; Peter A McCullough
Journal:  Congest Heart Fail       Date:  2003 Jan-Feb
View more
  23 in total

1.  Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe.

Authors:  Rgia A Othman; Semone B Myrie; David Mymin; Jean-Baptiste Roullet; Andrea E DeBarber; Robert D Steiner; Peter J H Jones
Journal:  J Pediatr       Date:  2017-06-16       Impact factor: 4.406

2.  Hypothyroid heart: myxoedema as a cause of reversible dilated cardiomyopathy.

Authors:  Nidhi Madan; Nidhish Tiwari; Morris Stampfer; Ulrich Schubart
Journal:  BMJ Case Rep       Date:  2015-10-14

3.  Shifts in sensitivity of amphibian metamorphosis to endocrine disruption: the common frog (Rana temporaria) as a case study.

Authors:  Katharina Ruthsatz; Kathrin H Dausmann; Katharina Paesler; Patricia Babos; Nikita M Sabatino; Myron A Peck; Julian Glos
Journal:  Conserv Physiol       Date:  2020-12-14       Impact factor: 3.079

Review 4.  Postoperative atrial fibrillation: mechanism, prevention, and future perspective.

Authors:  Yasushige Shingu; Suguru Kubota; Satoru Wakasa; Tomonori Ooka; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  Surg Today       Date:  2012-05-23       Impact factor: 2.549

Review 5.  Thyroid Dysfunction and Heart Failure: Mechanisms and Associations.

Authors:  Hernando Vargas-Uricoechea; Anilza Bonelo-Perdomo
Journal:  Curr Heart Fail Rep       Date:  2017-02

6.  Thyroid Hormone Increases TGF-beta1 in Cardiomyocytes Cultures Independently of Angiotensin II Type 1 and Type 2 Receptors.

Authors:  Gabriela Placoná Diniz; Marcela Sorelli Carneiro-Ramos; Maria Luiza Morais Barreto-Chaves
Journal:  Int J Endocrinol       Date:  2010-06-02       Impact factor: 3.257

Review 7.  Thyroid hormones and heart failure.

Authors:  Felipe Martinez
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

Review 8.  Thyrotoxic cardiac disease.

Authors:  Peter Dahl; Sara Danzi; Irwin Klein
Journal:  Curr Heart Fail Rep       Date:  2008-09

9.  Mitochondrial and energetic cardiac phenotype in hypothyroid rat. Relevance to heart failure.

Authors:  Yoni Athéa; Anne Garnier; Dominique Fortin; Lahoucine Bahi; Vladimir Veksler; Renée Ventura-Clapier
Journal:  Pflugers Arch       Date:  2007-07-19       Impact factor: 3.657

Review 10.  Cardiac hypertrophy and thyroid hormone signaling.

Authors:  Wolfgang Dillmann
Journal:  Heart Fail Rev       Date:  2009-01-06       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.